MatthewLAndersonMDPhD
Obstetrics & Gynecology • Tampa, FLGynecologic Oncology
Professor, Gynecologic Oncology and Molecular Pharmacology & Physiology University of South Florida Morsani College of Medicine Associate Director for Shared Resources, Tampa General Hospital Cancer Institute
Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Tampa General Circle
Suite 6005 STC
Tampa, FL 33606Phone+1 813-259-8512Fax+1 813-259-8593
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1999 - 2002
Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1995 - 1999
Yale School of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2018 - 2027
TX State Medical License 2000 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Start of enrollment: 2020 Jul 23
- Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers Start of enrollment: 2019 Feb 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsAssessment of the Histone Mark-based Epigenomic Landscape in Human Myometrium at Term Pregnancy.San-Pin Wu, Elvis Quiroz, Tianyuan Wang, Skylar Montague Redecke, Xin Xu
Biorxiv. 2025-02-26 - Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis.Ayesha B Alvero, Sharon Wu, Alex Farrell, Seongho Kim, John J Wallbillich
Gynecologic Oncology. 2025-02-18 - Spatially restricted ecto-5'-nucleotidase expression promotes the growth of uterine leiomyomas by modulating Akt activity.Xiaofang Guo, Maja Okuka, Brittney Short, Asli Ozmen, Nihan Semerci Gunay
FASEB Journal. 2024-10-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
